fgf1 is required for normal differentiation of erythrocytes in zebrafish primitive hematopoiesis

Developmental Dynamics

Volumn 236, Issue 3, 2007, Pages 633-643

  Songhet, Pascal ^a   Adzic, Dejan ^a   Reibe, Saskia ^a   Rohr, Klaus B ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

AML; Fibroblast growth factor 1; gata1; Hematopoiesis; Ikaros; MDS; Zebrafish

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 1; IKAROS TRANSCRIPTION FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 1;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER RISK; CELL DIFFERENTIATION; CHROMOSOME 5Q; CHROMOSOME DELETION 5; EMBRYO; ERYTHROCYTE; GATA1 GENE; GENE; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN SITU HYBRIDIZATION; LEUKEMIA; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZEBRA FISH;

ANIMALS; CELL DIFFERENTIATION; ERYTHROCYTES; ERYTHROPOIESIS; FIBROBLAST GROWTH FACTOR 1; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IKAROS TRANSCRIPTION FACTOR; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO; VERTEBRATA;

EID: 33947401033     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21056     Document Type: Article

References (46)

1. Al-Adhami MA, Kunz YW. 1977. Ontogenesis of haematopoietic sites in Brachydanio rerio (Hamilton-Buchanan) (Teleostei). Dev Growth Differ 19:171-179.
2. Appel B, Givan LA, Eisen JS. 2001. Delta-Notch signaling and lateral inhibition in zebrafish spinal cord development. BMC Dev Biol 1:13.
3. Bennett CM, Kanki JP, Rhodes J, Liu TX, Paw BH, Kieran MW, Langenau DM, Delahaye-Brown A, Zon LI, Fleming MD, Look AT. 2001. Myelopoiesis in the zebrafish, Danio rerio. Blood 98:643-651.
4. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS. 1994. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 19:425-432.
5. Brownlie A, Donovan A, Pratt SJ, Paw BH, Oates AC, Brugnara C, Witkowska HE, Sassa S, Zon LI. 1998. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet 20:244-250.
6. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31:3497-3500.
7. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
8. Detrich HW III, Kieran MW, Chan FY, Barone LM, Yee K, Rundstadler JA, Pratt S, Ransom D, Zon LI. 1995. Intraembryonic hematopoietic cell migration during vertebrate development. Proc Natl Acad Sci U S A 92:10713-10717.
9. Fouquet B, Weinstein BM, Serluca FC, Fishman MC. 1997. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol 183:37-48.
10. Furthauer M, Van Celst J, Thisse C, Thisse B. 2004. Fgf signalling controls the dorsoventral patterning of the zebrafish embryo. Development 131:2853-2864.
11. Galloway JL, Wingert RA, Thisse C, Thisse B, Zon LI. 2005. Loss of gata1 but not gata2 converts erythropoiesis to myelopoiesis in zebrafish embryos. Dev Cell 8:109-116.
12. Gering M, Rodaway AR, Gottgens B, Patient RK, Green AR. 1998. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 17:4029-4045.
13. Gering M, Yamada Y, Rabbitts TH, Patient RK. 2003. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development 130:6187-6199.
14. Heicklen-Klein A, McReynolds LJ, Evans T. 2005. Using the zebrafish model to study GATA transcription factors. Semin Cell Dev Biol 16:95-106.
15. Hsia N, Zon LI. 2005. Transcriptional regulation of hematopoietic stem cell development in zebrafish. Exp Hematol 33: 1007-1014.
16. Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roeder D, Jackson A, Maier JA, Hla T, Maciag T. 1990. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567-1570.
17. Kalev-Zylinska ML, Horsfield JA, Flores MV, Postlethwait JH, Vitas MR, Baas AM, Crosier PS, Crosier KE. 2002. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 129:2015-2030.
18. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-3683.
19. Le Beau MM, Espinosa R III, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA. 1993. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A 90:5484-5488.
20. Lieschke GJ, Oates AC, Crowhurst MO, Ward AC, Layton JE. 2001. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 98:3087-3096.
21. Liu TX, Zhou Y, Kanki JP, Deng M, Rhodes J, Yang HW, Sheng XM, Zon LI, Look AT. 2002. Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. Proc Natl Acad Sci U S A 99:6136-6141.
22. Lyons SE, Lawson ND, Lei L, Bennett PE, Weinstein BM, Liu PP. 2002. A nonsense mutation in zebrafish gata1 causes the bloodless phenotype in vlad tepes. Proc Natl Acad Sci U S A 99:5454-5459.
23. Madiai F, Hackshaw K. 2002. Expression of the mouse FGF-1 and FGF-1.A mR-NAs during embryonic development and in the aging heart. Res Commun Mol Pathol Pharmacol 112:139-144.
24. Miller DL, Ortega S, Bashayan O, Basch R, Basilico C. 2000. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol 20:2260-2268.
25. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J. 1997. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276:955-960.
26. Nakazawa F, Nagai H, Shin M, Sheng G. 2006. Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood 108:3335-3343.
27. Nasevicius A, Ekker SC. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26:216-220.
28. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2:REVIEWS3005.
29. Powers CJ, McLeskey SW, Wellstein A. 2000. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7:165-197.
30. Quinkertz A, Campos-Ortega JA. 1999. A new beta-globin gene from the zebrafish, betaE1, and its pattern of transcription during embryogenesis. Dev Genes Evol 209:126-131.
31. Samuels BL, Larson RA, Le Beau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM. 1988. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79-83.
32. Thisse B, Thisse C, Weston JA. 1995. Novel FGF receptor (Z-FGFR4) is dynamically expressed in mesoderm and neurectoderm during early zebrafish embryogenesis. Dev Dyn 203:377-391.
33. Thompson MA, Ransom DG, Pratt SJ, MacLennan H, Kieran MW, Detrich HW III, Vail B, Huber TL, Paw B, Brownlie AJ, Oates AC, Fritz A, Gates MA, Amores A, Bahary N, Talbot WS, Her H, Beier DR, Postlethwait JH, Zon LI. 1998. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol 197:248-269.
34. Tonou-Fujimori N, Takahashi M, Onodera H, Kikuta H, Koshida S, Takeda H, Yamasu K. 2002. Expression of the FGF receptor 2 gene (fgfr2) during embryogenesis in the zebrafish Danio rerio. Gene Expr Patterns 2:183-188.
35. Trokovic R, Trokovic N, Hernesniemi S, Pirvola U, Vogt Weisenhorn DM, Rossant J, McMahon AP, Wurst W, Partanen J. 2003. FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals. EMBO J 22:1811-1823.
36. Trueb B, Neuhauss SC, Baertschi S, Rieckmann T, Schild C, Taeschler S. 2005. Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor. Biochim Biophys Acta 1727:65-74.
37. Van den Berghe H, Michaux L. 1997. 5q-, twenty-five years later: a synopsis. Cancer Genet Cytogenet 94:1-7.
38. Weiss MJ, Orkin SH. 1995. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 23:99-107.
39. Welch JJ, Watts JA, Vakoc CR, Yao Y, Wang H, Hardison RC, Blobel GA, Chodosh LA, Weiss MJ. 2004. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104:3136-3147.
40. Westerfield M. 2000. The zebrafish book. Guide for the laboratory use of zebrafish (Danio rerio). Eugene: University of Oregon Press.
41. Willett CE, Kawasaki H, Amemiya CT, Lin S, Steiner LA. 2001. Ikaros expression as a marker for lymphoid progenitors during zebrafish development. Dev Dyn 222: 694-698.
42. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, et al. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971.
43. Xie D, Hofmann WK, Mori N, Miller CW, Hoelzer D, Koeffler HP. 2000. Allelotype analysis of the myelodysplastic syndrome. Leukemia 14:805-810.
44. Yamauchi H, Hotta Y, Konishi M, Miyake A, Kawahara A, Itoh N. 2006. Fgf21 is essential for haematopoiesis in zebrafish. EMBO Rep 7:649-654.
45. Yeoh JS, van Os R, Weersing E, Ausema A, Dontje B, Vellenga E, de Haan G. 2006. Fibroblast growth factor-1 and 2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem Cells 24:1564-1572.
46. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R III, Larson RA, Le Beau MM. 1997. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci U S A 94:6948-6953.